Threestones Capital Logo
Dataroom Access

Investor Documents

Access Key Investor Information Documents and fund documentation for investors.

 
Kiel ophthalmology clinic

Threestones Capital Acquires an Ophthalmology Clinic in Kiel, Germany for TSC Fund – Eurocare IV

Luxembourg, September 2025 – Threestones Capital is pleased to announce the acquisition of an ophthalmology clinic located in the municipality of Kiel in the federal state of Schleswig-Holstein, Germany. The property is acquired through the investment vehicle TSC Fund – Eurocare IV.

The facility comprises two interconnected buildings: a historic Wilhelminian-style villa built in 1902 and a modern annex completed in 2015. This combination of preserved architecture and contemporary design results in a functional and representative healthcare environment. The total lettable area exceeds 3,500 square meters. The clinic includes 32 beds across 12 patient rooms and features 4 surgical theatres.


Kiel

As one of Germany’s most established eye surgery centres, the clinic is operated by a renowned healthcare group with a network of over 20 locations across the country.

“This property is a valuable addition to the Eurocare IV Fund. It marks Threestones Capital’s first acquisition in the ophthalmology sector and further strengthens our diversified portfolio across key medical and care segments.”

Michael Krantz, Senior Portfolio Manager at Threestones Capital

Threestones was advised by K&L Gates (legal), Savills (valuation), Dreess & Sommer (technical) and TSC Real Estate Germany (advisor).


Kiel property
Threestones Capital
[email protected]

Threestones Capital Management S.A. is an authorized Alternative Investment Fund Manager (AIFM) headquartered in Luxembourg. The company manages approximately EUR 2 billion in four Real Estate regulated investment vehicles under the supervision of the Luxembourg financial authorities (CSSF), in compliance with European financial regulations. Founded in 2009, Threestones Capital primarily focuses on real estate investments across Europe, targeting healthcare real estate. The company’s investors are a diverse mix of family offices and institutional investors. Investor Relations: [email protected]



Cookie Settings